Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
about
A rapid and sensitive LC-MS/MS method for quantification of donepezil and its active metabolite, 6-o-desmethyl donepezil in human plasma and its pharmacokinetic application.Cholinergic enhancement increases the effects of voluntary attention but does not affect involuntary attention.Review article: the pharmacological treatment of acute colonic pseudo-obstruction.Assessing the prospect of donepezil in improving cognitive impairment in patients with schizophrenia.The safety and tolerability of donepezil in patients with Alzheimer's disease.Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.Repeated dosing with donepezil does not affect the safety, tolerability or pharmacokinetics of single-dose thioridazine in young volunteers.Steady-state pharmacokinetics and safety of donepezil HCl in subjects with moderately impaired renal functionConcurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple oral doses.Steady-state pharmacokinetics, pharmacodynamics and tolerability of donepezil hydrochloride in hepatically impaired patients.Cholinergic enhancement reduces orientation-specific surround suppression but not visual crowding.Donepezil: an update.Donepezil for Alzheimer's disease.Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesteraseCholinergic enhancement reduces spatial spread of visual responses in human early visual cortexDonepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats.Cholinergic interactions between donepezil and prucalopride in human colon: potential to treat severe intestinal dysmotilityCholinergic Potentiation Improves Perceptual-Cognitive Training of Healthy Young Adults in Three Dimensional Multiple Object TrackingSmall molecular floribundiquinone B derived from medicinal plants inhibits acetylcholinesterase activity.Bioequivalence study of donepezil hydrochloride tablets in healthy male volunteersPharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses.Cholinergic, But Not Dopaminergic or Noradrenergic, Enhancement Sharpens Visual Spatial Perception in Humans.Cognitive function and cholinergic transmission in patients with subcortical vascular dementia and microbleeds: a TMS study.Neither Cholinergic Nor Dopaminergic Enhancement Improve Spatial Working Memory Precision in Humans.Synthesis, Molecular Modeling, and Evaluation of Novel Sulfonylhydrazones as Acetylcholinesterase Inhibitors for Alzheimer's Disease.Prolonged altered mental status and bradycardia following pediatric donepezil ingestion.Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer's disease.Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic reviewApplication of donepezil increased collagen 1 expression in mesenchymal stroma cells of an ovine osteoporosis model
P2860
Q33770846-FBC85A56-7429-40B6-84CF-8C16B44BCCFFQ34300082-5578FE83-551F-4B6B-8C48-9C8BFFFFF738Q34421482-87B0DDD5-84DD-4310-B6A4-3E487B0088FCQ34502083-B1C3F47B-B720-4DDD-9845-37E8945F8D48Q34552035-7DC095C3-C598-4554-81E6-6F3E62C41A67Q34648742-9203CF3B-5B4B-4B9D-9FAD-DEFCA589D68FQ35826244-413930E3-37F1-4A62-920F-0C3B7DB933E1Q35826248-8F1C994D-DAF6-4DD8-B41C-5A0355346F4AQ35826253-6100F8A3-74F9-4904-B7A6-2C092655BB20Q35826258-58FF287F-8889-4445-8944-C874DF7A67FCQ35826263-0EA244BE-C886-4C01-9699-BE008C9C7B4EQ36241033-6D84140B-A31C-4F4E-8914-07C1E67983B4Q36808057-502B7DB3-CF78-4343-A720-BA59C7382080Q36972671-D326D609-2C1C-4271-9E07-DF79853BC8BFQ37082335-6917B273-84BF-4B1D-B2EB-9F7A82A77323Q37093002-D4D58FFA-721B-4DEF-93BF-9CAC658B64AEQ37282357-2C6DC0C3-4208-4698-A1E1-E26A33491412Q37337891-D45EE82E-0034-474C-982B-771D575B27D6Q37712599-8D3C828E-235C-4118-97E9-4342C2FE6972Q41342817-0BF3FC93-37AD-4479-99CD-22B1956E0061Q41662439-C2E69A9C-2ED7-4593-91B4-A4E9E4E1F7FFQ41810856-DF82E979-7F7D-4D17-88B2-28DE0A9CF04EQ42356253-9661112A-C351-4A40-9854-2624FC67091BQ45329106-9EEF135B-8868-4A12-97F1-131D53D02101Q47148595-E85B2D07-DBD8-45D2-BE8E-F2A8F43CDF9DQ48100326-8A70DF35-F13F-4837-BB23-FCB1641E1CA5Q48112965-3043D8DF-5A44-4A38-938E-D9B0F00E59E4Q52645778-7F903025-140C-417C-9FD4-2EBE7091F5C8Q58698874-C2357A52-DF37-461A-93BF-32EDF585102AQ58774504-15D226BD-3142-4774-97DC-B8943DF5B96F
P2860
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
@ast
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
@en
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
@nl
type
label
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
@ast
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
@en
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
@nl
prefLabel
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
@ast
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
@en
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
@nl
P2860
P1476
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
@en
P2093
L T Friedhoff
S L Rogers
P2860
P356
10.1046/J.1365-2125.1998.0460S1001.X
P407
P478
46 Suppl 1
P577
1998-11-01T00:00:00Z